Skip to content

Study of a Prototype Software to Help Surgical Patients Manage Their Pain Medication

Evaluation of the Feasibility of an Expert Decision Support System for Patients Regarding the Optimization of the Management of Drugs With Conditional Administration in the Surgical Department: Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05707247
Acronym
MORPHEE 2
Enrollment
37
Registered
2023-01-31
Start date
2023-02-13
Completion date
2023-07-04
Last updated
2025-10-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-operative Situation

Keywords

prototype software, patient interface, experimental medical device

Brief summary

The experimental medical device is a prototype software. The device comes in the form of a smartphone with a touch interface. The smartphone used to support the software is a commercial smartphone marked CE. The study aims at assessing the feasibility of the use of this expert, patient- decision support systems. The study hypothesis is that the clinical use of the experimental device is feasible.

Interventions

DEVICEsoftware

The experimental medical device is a prototype software. It is a patient interface. The device comes in the form of a smartphone with a touch screen

Sponsors

University Hospital, Strasbourg, France
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or Female 18 years or older (no upper age limit) * Operated within a surgical department of of the Hautepierre University Hospitals of Strasbourg * Patient understanding and reading French * Subject neurosensorially able of interacting with a tactile electronical interface * Subject able to understand research objectives, risks and provide dated and signed informed consent * Subject covered by a health insurance scheme

Exclusion criteria

* Patient with neuropsychiatric or sensory disorders that may interfere with their use of the visual interface * Unable to provide informed information (subject in emergency, difficulty understanding the subject, etc.) * Pregnant or lactating woman (on declaration) * Patient under safeguard of justice, under guardianship, under curatorship

Design outcomes

Primary

MeasureTime frameDescription
To evaluate the feasibility of the INSAMED computer toolDay 2 post operativeagreement between INSAMED computer tool and the recommendations established by caregivers. The data from INSAMED computer tool will be collected by extracting the history of the digital interface (commercial smartphone) hosting the expert system.

Secondary

MeasureTime frameDescription
Evaluate the time delay, in usual care setting, of rescue drug administrations after surgery, to confirm the interest of developing expert systems to improve the existing one.60 minutes after software activationDelay, in minutes, between soliciting a ward nurse as usual practice (e.g., doorbell) and the administration of the therapeutic response. This time will be collected by the Research IDE during patient interview. 60 minutes after software activation. The patient will simultaneously request the standard care IDE (doorbell) and the INSAMED tool.
Assess patient satisfaction with usual care60 minutes after software activation.Patient satisfaction with the routine care therapeutic response measured by an analog visual scale between 0 and 100, measured 60 minutes after software activation.
Assess patient satisfaction with the ease of use of the experimental device60 minutes after software activation.Patient satisfaction with the ease of use of the INSAMED device measured by an analog visual scale between 0 and 100, measured 60 minutes after software activation
assess the security of the deviceDay 2 post operativeSafety analysis of INSAMED software through evaluation of serious adverse events based on a expert panel reviewing.

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026